Long-Term Protection with gp63 Vaccination Against Leishmania donovani in Mice
Author Information
Author(s): Saumyabrata Mazumder, Maji Mithun Das, Ali Nahid
Primary Institution: Indian Institute of Chemical Biology, Kolkata, India
Hypothesis
The study evaluates the potency, efficacy, and durability of different vaccination strategies against Leishmania donovani.
Conclusion
The DNA-prime/Protein-boost vaccination strategy resulted in robust immune responses and durable protection against L. donovani.
Supporting Evidence
- Vaccination with the DNA-prime/Protein-boost approach showed significantly enhanced immune responses.
- Long-term protection was achieved with a reduction in parasite load by 107 fold in the liver and 1010 fold in the spleen.
- HPB vaccination induced a mixed Th1/Th2 response before infection and polarized towards Th1 after challenge.
Takeaway
Researchers tested different vaccines to see which one helps mice fight off a disease caused by a tiny bug, and found that a special combination worked best.
Methodology
The study involved immunizing BALB/c mice with various vaccine regimens and measuring immune responses and parasite loads after challenge infection.
Limitations
The study was conducted in a murine model, which may not fully replicate human responses.
Participant Demographics
BALB/c mice, 4-6 weeks old.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website